EP4373499 - PROMOTING IMMUNE SURVEILLANCE AGAINST CANCER CELLS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.04.2024 Database last updated on 02.08.2024 | |
Former | The international publication has been made Status updated on 27.01.2023 | Most recent event Tooltip | 27.04.2024 | Publication in section I.1 EP Bulletin | published on 29.05.2024 [2024/22] | 27.04.2024 | Request for examination filed | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states Mayo Foundation for Medical Education and Research 200 First Street S.W. Rochester, Minnesota 55905 / US | [2024/22] | Inventor(s) | 01 /
VAN DEURSEN, Jan M.A. Rochester, Minnesota 55902-3421 / US | 02 /
LI, Hu Rochester, Minnesota 55902-1546 / US | 03 /
STURMLECHNER, Ines Rochester, Minnesota 55901 / US | 04 /
DAVID, Nathaniel Eames San Francisco, California 94108 / US | [2024/22] | Representative(s) | Fish & Richardson P.C. Highlight Business Towers Mies-van-der-Rohe-Straße 8 80807 München / DE | [2024/22] | Application number, filing date | 22846828.6 | 21.07.2022 | [2024/22] | WO2022US73986 | Priority number, date | US202163224177P | 21.07.2021 Original published format: US 202163224177 P | [2024/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023004377 | Date: | 26.01.2023 | Language: | EN | [2023/04] | Type: | A1 Application with search report | No.: | EP4373499 | Date: | 29.05.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.01.2023 takes the place of the publication of the European patent application. | [2024/22] | Search report(s) | International search report - published on: | US | 26.01.2023 | Classification | IPC: | A61K35/13, C07K16/24, G01N33/574, C07K16/28 | [2024/22] | CPC: |
A61K38/195 (EP);
A61K31/519 (EP);
A61K31/52 (EP);
A61K39/395 (EP);
A61K47/6811 (EP);
A61K47/6851 (EP);
C07K16/24 (EP);
C07K16/2815 (EP);
A61K2039/505 (EP);
C07K2317/70 (EP);
C07K2317/73 (EP);
C07K2317/76 (EP);
G01N33/5047 (EP);
G01N33/505 (EP);
G01N33/5055 (EP);
G01N33/5067 (EP)
(-)
| C-Set: |
A61K39/395, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/22] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | FÖRDERUNG DER IMMUNÜBERWACHUNG GEGEN KREBSZELLEN | [2024/22] | English: | PROMOTING IMMUNE SURVEILLANCE AGAINST CANCER CELLS | [2024/22] | French: | PROMOTION DE LA SURVEILLANCE IMMUNITAIRE CONTRE DES CELLULES CANCÉREUSES | [2024/22] | Entry into regional phase | 19.02.2024 | National basic fee paid | 19.02.2024 | Search fee paid | 19.02.2024 | Designation fee(s) paid | 19.02.2024 | Examination fee paid | Examination procedure | 19.02.2024 | Amendment by applicant (claims and/or description) | 19.02.2024 | Examination requested [2024/22] | Fees paid | Renewal fee | 19.02.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YA]US9850306 (BEDI ATUL [US], et al) [Y] 1-2, 4-5, 19-20 * ; column 13, line 66; column 27, line 25-26; column 31, lines 14-15 & 16-17 & 18-19; column 42, lines 4-5 & lines 10-12; * [A] 3, 6; | [YA] - Hara T., Tanegashima K., "Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals", Journal of Biochemistry, Oxford University Press, GB, GB , (20120501), vol. 151, no. 5, doi:10.1093/jb/mvs030, ISSN 0021-924X, pages 469 - 476, XP093028027 [Y] 1-2, 4-5, 19-20 [A] 3, 6 DOI: http://dx.doi.org/10.1093/jb/mvs030 | [Y] - FOUCHER, ED et al., "IL -34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNc", PLOS ONE, (20130208), vol. 8, no. 2, doi:10.1371/journal.pone.0056045, pages 1 - 10, XP055213470 [Y] 19-20 DOI: http://dx.doi.org/10.1371/journal.pone.0056045 | [A] - Alves Eric, Taifour Shahama, Dolcetti Riccardo, Chee Jonathan, Nowak Anna K., Gaudieri Silvana, Blancafort Pilar, "Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing", Molecular therapy- methods & clinical development, Nature Publishing Group, GB, GB , (20210601), vol. 21, doi:10.1016/j.omtm.2021.04.009, ISSN 2329-0501, pages 592 - 606, XP093028025 [A] 3, 6 DOI: http://dx.doi.org/10.1016/j.omtm.2021.04.009 |